Amgen Inc
AMGN.MX
| Exchange: | MX |
| Currency | Mexican Peso |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Drug Manufacturers - General |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Pharmaceuticals |
| Gic Sub Industry: | Pharmaceuticals |
| Description: | Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Astra Zeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and Bei Gene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. |
| Address: | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 |
| Website: | https://www.amgen.com |
| Full Time Employees: | 26700 |
| Updated On: | 2024-11-04 |
Highlights
| Market Capitalization: | 3455444844544 |
| Market Capitalization Mln: | 3455444.84 |
| EBITDA: | 12247000064 |
| PE Ratio: | 40.98 |
| PEG Ratio: | 2.20 |
| Book Value: | 14.00 |
| Dividend Share: | 8.88 |
| Dividend Yield: | 0.02 |
| Earnings Share: | 156.85 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.13 |
| Operating Margin TTM: | 0.24 |
| Return On Assets TTM: | 0.04 |
| Return On Equity TTM: | 0.55 |
| Revenue TTM: | 32533999616 |
| Revenue Per Share TTM: | 60.64 |
| Quarterly Revenue Growth YOY: | 0.23 |
| Gross Profit TTM: | 19917000000 |
| Diluted Eps TTM: | 156.85 |
| Quarterly Earnings Growth YOY: | 0.62 |
Valuation
| Trailing PE: | 40.98 |
| Forward PE: | 15.52 |
| Price Sales TTM: | 106.21 |
| Price Book MRQ: | 22.87 |
| Enterprise Value: | 4474971710052 |
| Enterprise Value Revenue: | 6.85 |
| Enterprise Value Ebitda: | 16.53 |
Shares
| Shares Outstanding: | 537532992 |
| Shares Float: | 536043757 |
| Percent Insiders: | 0.25 |
| Percent Institutions: | 81.90 |
Technicals
| Beta: | 0.60 |
| 52 Week High: | 6612 |
| 52 Week Low: | 4384.72 |
| 50 Day MA: | 6409.73 |
| 200 Day MA: | 5505.35 |
Splits & Dividends
| Forward Annual Dividend Rate: | 179.95 |
| Forward Annual Dividend Yield: | 0.02 |
| Payout Ratio: | 0.03 |
| Ex Dividend Date: | 2024-11-19 |
Earnings
| Report Date: | 2025-10-28 |
| Date: | 2025-09-30 |
| Before After Market: | Before Market |
| Currency: | MXN |
| Report Date: | 2025-04-30 |
| Date: | 2025-03-31 |
| Before After Market: | Before Market |
| Currency: | MXN |
| Report Date: | 2025-02-04 |
| Date: | 2024-12-31 |
| Before After Market: | Before Market |
| Currency: | MXN |
| Report Date: | 2024-10-30 |
| Date: | 2024-09-30 |
| Before After Market: | After Market |
| Currency: | MXN |
| Report Date: | 2024-08-06 |
| Date: | 2024-06-30 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 23.78 |
| Report Date: | 2024-05-02 |
| Date: | 2024-03-31 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | -3.58 |
| Report Date: | 2024-03-05 |
| Date: | 2023-12-31 |
| Before After Market: | Before Market |
| Currency: | MXN |
| Eps Actual: | 24.95 |
| Report Date: | 2023-10-31 |
| Date: | 2023-09-30 |
| Before After Market: | Before Market |
| Currency: | MXN |
| Eps Actual: | 54.86 |
| Report Date: | 2023-08-03 |
| Date: | 2023-06-30 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 45.41 |
| Report Date: | 2023-04-27 |
| Date: | 2023-03-31 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 98.52 |
| Report Date: | 2023-02-07 |
| Date: | 2022-12-31 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 59.00 |
| Report Date: | 2022-11-03 |
| Date: | 2022-09-30 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 80.64 |
| Report Date: | 2022-08-04 |
| Date: | 2022-06-30 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 49.18 |
| Report Date: | 2022-04-27 |
| Date: | 2022-03-31 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 54.92 |
| Report Date: | 2022-02-07 |
| Date: | 2021-12-31 |
| Before After Market: | After Market |
| Currency: | MXN |
| Eps Actual: | 69.76 |
| Report Date: | 2021-11-02 |
| Date: | 2021-09-30 |
| Currency: | MXN |
| Eps Actual: | 66.21 |
| Report Date: | 2021-08-03 |
| Date: | 2021-06-30 |
| Currency: | MXN |
| Eps Actual: | 16.11 |
| Report Date: | 2021-04-27 |
| Date: | 2021-03-31 |
| Currency: | MXN |
| Eps Actual: | 57.67 |
| Report Date: | 2021-02-02 |
| Date: | 2020-12-31 |
| Currency: | MXN |
| Eps Actual: | 56.74 |
| Report Date: | 2020-09-30 |
| Date: | 2020-09-30 |
| Currency: | MXN |
| Eps Actual: | 75.79 |
| Report Date: | 2020-06-30 |
| Date: | 2020-06-30 |
| Currency: | MXN |
| Eps Actual: | 70.99 |
| Report Date: | 2020-03-31 |
| Date: | 2020-03-31 |
| Currency: | MXN |
| Eps Actual: | 61.58 |
| Report Date: | 2019-12-31 |
| Date: | 2019-12-31 |
| Currency: | MXN |
| Eps Actual: | 54.82 |
| Report Date: | 2019-09-30 |
| Date: | 2019-09-30 |
| Currency: | MXN |
| Eps Actual: | 63.52 |
| Report Date: | 2019-06-30 |
| Date: | 2019-06-30 |
| Currency: | MXN |
| Eps Actual: | 68.29 |
| Report Date: | 2019-03-31 |
| Date: | 2019-03-31 |
| Currency: | MXN |
| Eps Actual: | 61.10 |
| Report Date: | 2018-12-31 |
| Date: | 2018-12-31 |
| Currency: | MXN |
| Eps Actual: | 59.71 |
| Report Date: | 2018-09-30 |
| Date: | 2018-09-30 |
| Currency: | MXN |
| Eps Actual: | 54.29 |
| Report Date: | 2018-06-30 |
| Date: | 2018-06-30 |
| Currency: | MXN |
| Eps Actual: | 67.56 |
| Report Date: | 2018-03-31 |
| Date: | 2018-03-31 |
| Currency: | MXN |
| Eps Actual: | 60.88 |
| Report Date: | 2017-12-31 |
| Date: | 2017-12-31 |
| Currency: | MXN |
| Eps Actual: | -111.71 |
| Report Date: | 2017-09-30 |
| Date: | 2017-09-30 |
| Currency: | MXN |
| Eps Actual: | 49.15 |
| Report Date: | 2017-06-30 |
| Date: | 2017-06-30 |
| Currency: | MXN |
| Eps Actual: | 54.04 |
| Report Date: | 2017-03-31 |
| Date: | 2017-03-31 |
| Currency: | MXN |
| Eps Actual: | 56.74 |
| Report Date: | 2016-12-31 |
| Date: | 2016-12-31 |
| Currency: | MXN |
| Eps Actual: | 51.34 |
| Report Date: | 2016-09-30 |
| Date: | 2016-09-30 |
| Currency: | MXN |
| Eps Actual: | 50.25 |
| Report Date: | 2016-06-30 |
| Date: | 2016-06-30 |
| Currency: | MXN |
| Eps Actual: | 44.79 |
| Report Date: | 2016-03-31 |
| Date: | 2016-03-31 |
| Currency: | MXN |
| Eps Actual: | 45.12 |
| Report Date: | 2015-12-31 |
| Date: | 2015-12-31 |
| Currency: | MXN |
| Eps Actual: | 39.62 |
| Report Date: | 2015-09-30 |
| Date: | 2015-09-30 |
| Currency: | MXN |
| Eps Actual: | 40.06 |
| Report Date: | 2015-06-30 |
| Date: | 2015-06-30 |
| Currency: | MXN |
| Eps Actual: | 32.99 |
| Report Date: | 2015-03-31 |
| Date: | 2015-03-31 |
| Currency: | MXN |
| Eps Actual: | 31.51 |
| Report Date: | 2014-12-31 |
| Date: | 2014-12-31 |
| Currency: | MXN |
| Eps Actual: | 23.25 |
| Report Date: | 2014-09-30 |
| Date: | 2014-09-30 |
| Currency: | MXN |
| Eps Actual: | 21.16 |
| Report Date: | 2014-06-30 |
| Date: | 2014-06-30 |
| Currency: | MXN |
| Eps Actual: | 26.18 |
| Report Date: | 2014-03-31 |
| Date: | 2014-03-31 |
| Currency: | MXN |
| Eps Actual: | 18.49 |
| Report Date: | 2013-12-31 |
| Date: | 2013-12-31 |
| Currency: | MXN |
| Eps Actual: | 17.36 |
| Report Date: | 2013-09-30 |
| Date: | 2013-09-30 |
| Currency: | MXN |
| Eps Actual: | 23.05 |
| Report Date: | 2013-06-30 |
| Date: | 2013-06-30 |
| Currency: | MXN |
| Eps Actual: | 20.54 |
| Report Date: | 2013-03-31 |
| Date: | 2013-03-31 |
| Currency: | MXN |
| Eps Actual: | 23.73 |
| Report Date: | 2012-12-31 |
| Date: | 2012-12-31 |
| Currency: | MXN |
| Eps Actual: | 13.10 |
| Report Date: | 2012-09-30 |
| Date: | 2012-09-30 |
| Currency: | MXN |
| Eps Actual: | 18.62 |
| Report Date: | 2012-06-30 |
| Date: | 2012-06-30 |
| Currency: | MXN |
| Eps Actual: | 21.84 |
| Report Date: | 2012-03-31 |
| Date: | 2012-03-31 |
| Currency: | MXN |
| Eps Actual: | 19.19 |
| Report Date: | 2011-12-31 |
| Date: | 2011-12-31 |
| Currency: | MXN |
| Eps Actual: | 14.79 |
| Report Date: | 2011-09-30 |
| Date: | 2011-09-30 |
| Currency: | MXN |
| Eps Actual: | 6.12 |
| Report Date: | 2011-06-30 |
| Date: | 2011-06-30 |
| Currency: | MXN |
| Eps Actual: | 14.67 |
| Report Date: | 2011-03-31 |
| Date: | 2011-03-31 |
| Currency: | MXN |
| Eps Actual: | 14.41 |
| Report Date: | 2010-12-31 |
| Date: | 2010-12-31 |
| Currency: | MXN |
| Eps Actual: | 13.38 |
| Report Date: | 2010-09-30 |
| Date: | 2010-09-30 |
| Currency: | MXN |
| Eps Actual: | 16.44 |
| Report Date: | 2010-06-30 |
| Date: | 2010-06-30 |
| Currency: | MXN |
| Eps Actual: | 15.67 |
| Report Date: | 2010-03-31 |
| Date: | 2010-03-31 |
| Currency: | MXN |
| Eps Actual: | 15.07 |
| Report Date: | 2009-12-31 |
| Date: | 2009-12-31 |
| Currency: | MXN |
| Eps Actual: | 12.02 |
| Report Date: | 2009-09-30 |
| Date: | 2009-09-30 |
| Currency: | MXN |
| Eps Actual: | 17.98 |
| Report Date: | 2009-06-30 |
| Date: | 2009-06-30 |
| Currency: | MXN |
| Eps Actual: | 16.63 |
| Report Date: | 2009-03-31 |
| Date: | 2009-03-31 |
| Currency: | MXN |
| Eps Actual: | 14.12 |
| Report Date: | 2008-12-31 |
| Date: | 2008-12-31 |
| Currency: | MXN |
| Eps Actual: | 11.81 |
| Report Date: | 2008-09-30 |
| Date: | 2008-09-30 |
| Currency: | MXN |
| Eps Actual: | 11.23 |
| Report Date: | 2008-06-30 |
| Date: | 2008-06-30 |
| Currency: | MXN |
| Eps Actual: | 9.07 |
| Report Date: | 2008-03-31 |
| Date: | 2008-03-31 |
| Currency: | MXN |
| Eps Actual: | 11.24 |
| Report Date: | 2007-12-31 |
| Date: | 2007-12-31 |
| Currency: | MXN |
| Eps Actual: | 8.29 |
| Report Date: | 2007-09-30 |
| Date: | 2007-09-30 |
| Currency: | MXN |
| Eps Actual: | 2.02 |
| Report Date: | 2007-06-30 |
| Date: | 2007-06-30 |
| Currency: | MXN |
| Eps Actual: | 9.77 |
| Date: | 2024-09-30 |
| Eps Actual: | 20.20 |
| Date: | 2023-12-31 |
| Eps Actual: | 223.76 |
| Date: | 2022-12-31 |
| Eps Actual: | 243.76 |
| Date: | 2021-12-31 |
| Eps Actual: | 209.76 |
| Date: | 2020-12-31 |
| Eps Actual: | 265.12 |
| Date: | 2019-12-31 |
| Eps Actual: | 247.75 |
| Date: | 2018-12-31 |
| Eps Actual: | 242.46 |
| Date: | 2017-12-31 |
| Eps Actual: | 48.22 |
| Date: | 2016-12-31 |
| Eps Actual: | 191.52 |
| Date: | 2015-12-31 |
| Eps Actual: | 144.20 |
| Date: | 2014-12-31 |
| Eps Actual: | 89.09 |
| Date: | 2013-12-31 |
| Eps Actual: | 84.69 |
| Date: | 2012-12-31 |
| Eps Actual: | 72.77 |
| Date: | 2011-12-31 |
| Eps Actual: | 50.00 |
| Date: | 2010-12-31 |
| Eps Actual: | 60.57 |
| Date: | 2009-12-31 |
| Eps Actual: | 60.77 |
| Date: | 2008-12-31 |
| Eps Actual: | 43.37 |
| Date: | 2007-12-31 |
| Eps Actual: | 20.09 |